BC Conservatives Demand Gene Therapy Funding for Toddler

Gurmoh Gill's family faces a desperate race against time as the only effective treatment—a gene therapy costing millions—remains unfunded by the province. The Conservatives argue that failing to pay now will cost more in lifelong care and lost potential. They demand immediate action to save the child's life and set a precedent for future cases.

The therapy offers a potential cure, but BC's pharmacare program excludes such expensive treatments for rare diseases. Critics say the system prioritizes cost over outcomes, forcing families into fundraising or bankruptcy. This case highlights the growing tension between budget constraints and medical innovation.

Similar therapies have gained approval in other provinces, raising questions about BC's lagging approach. The Conservatives' push could force a policy shift or at least a temporary compassionate coverage. Political pressure is mounting as the story gains public sympathy and media traction.

Power Move: This case could become a catalyst for BC to overhaul rare disease funding, potentially saving millions in long-term care costs while securing political capital. Expect the government to announce a review or emergency funding within weeks to defuse the crisis.

This article was edited with AI assistance for readability. Read original here.